Cameroon vs Central African Republic: Rate of disease burden from drug use disorders who
Cameroon
39.39
in 2021
Central African Republic
41.95
in 2021
Cameroon rank
178th
Central African Republic rank
176th
Rate of disease burden from drug use disorders who over time
- Cameroon
- Central African Republic
How they compare
Central African Republic currently reports 41.95 against 39.39 in Cameroon, a difference of 2.56.
That makes Central African Republic's figure about 1.1 times Cameroon's.
Across all 22 years both countries report, Central African Republic has been ahead every year.
Cameroon ranks 178th and Central African Republic ranks 176th of 194 countries.
Central African Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Central African Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.06 | 44.49 | 7.43 | Central African Republic |
| 2010s | 39.09 | 43.03 | 3.93 | Central African Republic |
| 2020s | 39.38 | 41.69 | 2.31 | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher rate of disease burden from drug use disorders who, Cameroon or Central African Republic?
- Central African Republic, at 41.95 against 39.39 in Cameroon as of 2021.
- What is the difference in rate of disease burden from drug use disorders who between Cameroon and Central African Republic?
- 2.56, with Central African Republic ahead.
- How many years of comparable data are there for Cameroon and Central African Republic?
- 22 years are reported by both, from 2000 to 2021.
- How do Cameroon and Central African Republic rank globally for rate of disease burden from drug use disorders who?
- Cameroon ranks 178th and Central African Republic ranks 176th of 194 countries.
- Where does this data come from?
- Our World in Data, published as Rate of disease burden from drug use disorders who. Statizoid refreshes it automatically from the source and publishes the full history for both places.